{"id":"06c08707-6022-4b8c-9bcb-1dae3b5382ae","kind":"institutions","code":"UB-I7183","name":"Chengdu Hongsheng Phase One Venture Capital Partnership (Limited Partnership)","nameBasis":"transliterated","summary":"Chengdu Hongsheng Phase One Venture Capital Partnership (Limited Partnership), a venture capital firm focused on technology investments.","description":"Chengdu Hongsheng Phase One Venture Capital Partnership (Limited Partnership), a venture capital firm focused on technology investments.","country":null,"category":null,"originalName":"成都弘生一期创业投资合伙企业（有限合伙）","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T17:00:20.831Z","englishUpdatedAt":"2026-10-15T18:35:34.832Z","reviewedAt":"2026-10-15T18:35:34.832Z","snapshotAt":"2026-10-15T18:31:23.182Z","sourceHash":"38b52c14ec8cf34f9b0ec52efd91317f809887bd822fca9e3f4b29d8786beef9","companyId":null,"foundedYear":null,"logoUrl":null,"originalText":"成都弘生一期创业投资合伙企业（有限合伙），一家专注科技领域投资的风险投资机构。","sources":[],"related":[{"id":"e37154eb-94be-495a-ab4e-09c59b06a289","kind":"news","code":"e37154eb-94be-495a-ab4e-09c59b06a289","name":"iRegene completes equity financing","nameBasis":"translated-title","summary":"On 2026-08-18, according to Xiniu Data, iRegene completed equity financing for an undisclosed amount. Investors were Sichuan Shengchengguozhuanhua Investment Yindao Fund Partnership (Limited Partnership), Chengdu Hongsheng Phase One Venture Capital Partnership (Limited Partnership), Wuxi City Biotechnology Pharmaceutical Industry Fund (Limited Partnership), Shenzhen City Pengyuanjishi Private Equity Investment Fund Partnership (Limited Partnership), Chengdu Weilai Industry Venture Capital Development Fund Partnership (Limited Partnership), Shanghai Dingtaixing Technology Development Co., Ltd.. The company is a developer of chemically induced cell therapy drugs.","description":"","country":null,"category":null,"originalName":"睿健医药完成股权投资融资","eventDate":"2026-08-18T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-15T16:32:28.601Z","englishUpdatedAt":"2026-10-20T18:31:05.523Z","reviewedAt":"2026-10-20T18:31:05.523Z","snapshotAt":"2026-10-20T18:19:32.670Z","sourceHash":"abf9659134ce75b3903fd4a6d6f19c9eda5a856f217dd09cec3da4e63654f1a6","companyId":"c6f40f74-5248-4720-8404-fd1e03022e90","foundedYear":null,"logoUrl":null,"path":"/news/e37154eb-94be-495a-ab4e-09c59b06a289"}],"path":"/institutions/chengdu-hongsheng-phase-one-venture-capital-partnership-limited-partnership","displayName":"成都弘生一期创业投资合伙企业（有限合伙）","displayNameLang":"zh","structured":{"city":null,"country":"China (mainland)","location":null,"role":null,"category":null,"company":null},"definition":"成都弘生一期创业投资合伙企业（有限合伙） is a venture capital investor based in China (mainland) with 1 recorded investment.","summaryBasis":"translated","thin":false,"canonical":"https://uniquebase.ai/institutions/chengdu-hongsheng-phase-one-venture-capital-partnership-limited-partnership"}